A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial

Autor:	Bright, George M., Thorner, Michael O.
Rok vydání:	2022
Předmět:	Endocrinology Human Growth Hormone Growth Hormone Secretagogues Endocrinology Diabetes and Metabolism Pediatrics Perinatology and Child Health Humans Insulin-Like Growth Factor I Child Dwarfism Pituitary Glucagon Hypoglycemia Research Article
Zdroj:	Horm Res Paediatr
ISSN:	1663-2826 1663-2818
DOI:	10.1159/000524244
Popis:	Introduction: LUM-201 (ibutamoren, formerly MK-0677) is an orally administered GH secretagogue receptor agonist under development for treatment of pediatric growth hormone deficiency (PGHD). Methods: The GH response to a single dose of LUM-201 and to other GH secretagogues used for diagnosis of PGHD were compared in 68 pediatric subjects participating in a trial for growth hormone deficiency. Results: LUM-201 elicited greater GH responses than observed in GHD diagnostic tests with arginine, glucagon, clonidine, L-dopa, and insulin-induced hypoglycemia [median and interquartile ranges 15.0 ng/mL (3.5, 49) vs. 5.5 ng/mL (1.8, 7.6) (p < 0.0001)]. The difference between responses was greatest in subjects with higher baseline IGF-I concentrations and higher GH responses to standard GH stimuli. Conclusion: LUM-201 elicits greater GH responses than standard stimuli in subjects with higher peak GH in response to conventional testing and is potentially an orally administered treatment alternative to injectable rhGH in a subset of patients with adequate responses to an acute dose of LUM-201.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e1c5556acf11d62087e30a3320ca09 https://doi.org/10.1159/000524244 Zobrazit plný text záznamu